Abstract
Metabolic Syndrome (MS) is a group of pathologies (diabetes, dyslipidemia, hypertriglyceridemia, hypertension and obesity) associated to higher risk of mortality, cardiovascular events and high medical costs. MicroRNAs (miRNAs) are small noncoding RNA molecules with extensive gene regulatory activity. MiRNAs are involved in the pathophysiology of several metabolic diseases and, therefore,…